Company intelligence / Profile preview

Exactus

Ownership: Private
Development stage: Other

Overview

Panacea Life Sciences Holdings, formerly Exactus, Inc., is a vertically integrated company specializing in the production of hemp-derived cannabinoid products, primarily cannabidiol (CBD), for both consumer and veterinary markets. The company operates a cGMP-certified manufacturing facility and hemp farm, and its products include softgels, gummies, tinctures, cosmetics, and topicals. The previous Exactus, Inc. had a life science focus on point-of-care diagnostic devices, but all current operations are in cannabinoid consumer health.

Modalities: Small molecule
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Exactus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exactus.

Explore the full profile